Skip to main content
Log in

Genomic surveillance of MRSA cost saving in UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017/2018 British pounds

Reference

  • Dymond A, et al. Genomic surveillance of methicillin-resistant Staphylococcus aureus: a mathematical early modelling study of cost effectiveness. Clinical Infectious Diseases : 18 Jun 2019. Available from: URL: http://doi.org/10.1093/cid/ciz480

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genomic surveillance of MRSA cost saving in UK. PharmacoEcon Outcomes News 831, 17 (2019). https://doi.org/10.1007/s40274-019-6005-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6005-4

Navigation